Label Image (Lbl713351400)
Description not available.*
Tadalafil
Product Images NDC 71335-1400
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 71335-1400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 (Tadalafil Tablets Usp 1)
10 (Tadalafil Tablets Usp 2)
This appears to be a table showing the difference in blood pressure (in mmHg) between tadalafil and placebo, in both standing and supine positions, over time (in hours). It is not clear if the text in the middle of the table ("R i . G i") has any meaningful context, as it appears to be a scanning error.*
10 (Tadalafil Tablets Usp 3)
10 (Tadalafil Tablets Usp 4)
This appears to be a report on a study evaluating the effects of tadalafil and doxazosin on blood pressure. Different dosages of tadalafil and doxazosin were administered at 8:00 am and 8:00 pm, along with a placebo. Systolic blood pressure measurements were taken at different times after administration of the drugs. However, the output contains a lot of errors and is not completely readable.*
10 (Tadalafil Tablets Usp 5)
10 (Tadalafil Tablets Usp 6)
This text provides information about the change in IPSS total score with Tadalafil 5mg compared to placebo over the duration of treatment in weeks. The symbol next to Tadalafil 5mg suggests a statistically significant difference from placebo at a significance level of p<0.01.*
10 (Tadalafil Tablets Usp 7)
This is a description of a study involving Tadalafil 5 mg and Placebo. There is a statistical significance denoted by "*p<0.01". The study measured the change from baseline in IPSS Total Score over a period of time in weeks. No further information is provided.*
10 (Tadalafil Tablets Usp 8)
10 (Tadalafil Tablets Usp 9)
This text appears to be showing data from a clinical trial involving Tadalafil 5mg and a placebo. It compares the change from baseline in IPSS total score and indicates a statistically significant result with a p-value of less than 0.01. The duration of the treatment weeks is not specified.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
